In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to discuss low clinical trial participation in Black patients with breast cancer, and factors that may be contributing.
In part two of CURE’s “Breaking Barriers: Addressing Women of Color Underrepresentation in Clinical Trials” webinar, Ricki Fairley, CEO of TOUCH, The Black Breast Cancer Alliance; Hayley Brown, director of partnerships and programs at TOUCH, The Black Breast Cancer Alliance; and Michelle Anderson-Benjamin, CEO and founder of The Fearless Warrior Organization, discussed lower participation rates in clinical trials among Black women, and factors, like lack of education around breast cancer and its treatment as well as mistrust of medical providers, that may contribute to this low rate.
“It's so important, because we need to understand the science for Black women, we need to understand all the nuances that are different for Black women. And right now, we're not in the in the data,” Fairley said.
00:22 – Clinical trials and participation among Black women with breast cancer.
01:33 – Educating patients about clinical trials.
02:54 – Cancer treatment options and clinical trials.
03:58 – Cancer treatment and precision medicine among women of color.
05:13 – Medical mistrust and informed consent.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.